Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2635-2641

  Tryc, Anita Blanka ^a   Alwan, Güldan ^a   Bokemeyer, Martin ^a   Goldbecker, Annemarie ^a   Hecker, Hartmut ^a   Haubitz, Marion ^a   Weissenborn, Karin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

chronic kidney disease; cognitive dysfunction; haemodialysis; MR spectroscopy; uraemic encephalopathy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN METABOLISM; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LEARNING DISORDER; MALE; MEMORY DISORDER; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOMETRY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BRAIN DISEASES, METABOLIC; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 79961037656     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq729     Document Type: Article

References (38)

1. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004;107:1-16 (Pubitemid 39556672)
2. Kurella M, Chertow GM, Luan J et al. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004;52:1863-1869 (Pubitemid 41710270)
3. Jassal SV, Roscoe J, LeBlanc D et al. Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease. Int Urol Nephrol 2008;40:849-54
4. Hailpern SM, Melamed ML, Cohen HW et al. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2007;18:2205-2213 (Pubitemid 47044805)
5. Kurella M, Chertow GM, Fried LF et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005;16:2127-2133 (Pubitemid 41716444)
6. Murray AM, Tupper DE, Knopman DS et al. Cognitive impairment in hemodialysis patients is common. Neurology 2006;67:216-223 (Pubitemid 44305402)
7. De Deyn PP, D'Hooge R, Van Bogaert PP et al. Endogenous guanidino compounds as ureamic neurotoxins. Kidney Int Suppl 2001;78:S77-S83 (Pubitemid 32144075)
8. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007;357:1316-1325
9. Geissler A, Frund R, Kohler S et al. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy. Radiology 1995;194:693-697
10. Sasaki O, Hattori N, Nakahama H et al. Positive correlations between cerebral choline and renal dysfunction in chronic renal failure. Neuroradiology 2006;48:300-306 (Pubitemid 43733088)
11. Menon DK, Sandford RN, Cassidy MJ et al. Proton magnetic resonance spectroscopy in chronic renal failure. Lancet 1991;337:244-245
12. Michaelis T, Videen JS, Linsey MS et al. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease. J Magn Reson Imaging 1996;6:341-347 (Pubitemid 126701465)
13. Webb PG, Sailasuta N, Kohler SJ et al. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373 (Pubitemid 24108265)
14. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679 (Pubitemid 23360802)
15. Christensen A. Luria's Neuropsychological Investigation. Copenhagen, Denmark: Munksgaard; 1979
16. Bodemer I. der Wort-Bild-Gedächtnis-Test (WBGT): Ein neues Gedächtnisverfahren zur simultanen Prüfung von verbalem und figuralem Gedächtnis. Klinik für Neurologie und klinische Neurophysiologie. Hannover, Germany: Medizinische Hochschule Hannover; 1995
17. Bäumler G. Lern-und Gedächtnistest LGT-3. Göttingen, Germany: Verlag für Psychologie; 1974
18. Osterreith P. Le test de copie d'une figure complexe. Archives de psychologie 1944;30:465-467
19. Zimmermann P, Fimm B. Neuropsychologische Testbatterie zur Erfassung von Aufmerksamkeitsdefiziten-Revidierte Fassung. Freiburg, Germany: Psychologisches Institut der Universität Freiburg; 1989
20. Brickenkamp R. Test d2. Aufmerksamkeits-Belastungs-Test. Göttingen, Germany: Verlag für Psychologie; 1981
21. Schomerus H, Weissenbron K, Hamster W et al. PSE-Syndrom-Test. Psychodiagnostisches Verfahren zur quantitativen Erfassung der (minimalen) portosystemischen Enzephalopathie. Frankfurt, Germany: Swets Test Services; 1999
22. McIntyre DJ, Charlton RA, Markus HS et al. Long and short echo time proton magnetic resonance spectroscopic imaging of the healthy aging brain. J Magn Reson Imaging 2007;26:1596-1606 (Pubitemid 350291290)
23. Huang W, Alexander GE, Chang L et al. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1) H MRS study. Neurology 2001;57:626-32 (Pubitemid 32782989)
24. De Stefano N, Filippi M, Miller D et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 2007;69:1942-1952 (Pubitemid 350100353)
25. Benarroch EE. N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008;70:1353-1357 (Pubitemid 351550340)
26. Narayana PA, Doyle TJ, Lai D et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998;43:56-71 (Pubitemid 28124649)
27. Kalra S, Cashman NR, Genge A et al. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757-1761 (Pubitemid 28289180)
28. Page RA, Davie CA, MacManus D et al. Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease. Neurology 2004;63:638-643 (Pubitemid 39100818)
29. Weissenborn K, Bokemeyer M, Ahl B et al. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004;19:269-280 (Pubitemid 39361188)
30. Weissenborn K, Ahl B, Fischer-Wasels D et al. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 2007;56:1736-1742 (Pubitemid 350206301)
31. Spahr L, Burkhard PR, Grotzsch H et al. Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2002;17:399-413 (Pubitemid 36204769)
32. Gelb S, Shapiro RJ, Hill A et al. Cognitive outcome following kidney transplantation. Nephrol Dial Transplant 2008;23:1032-1038 (Pubitemid 351767548)
33. Wolcott DL, Wellisch DK, Marsh JT et al. Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis 1988;12:275-284
34. Griva K, Thompson D, Jayasena D et al. Cognitive functioning pre-to post-kidney transplantation-a prospective study. Nephrol Dial Transplant 2006;21:3275-3282 (Pubitemid 44567105)
35. Souheaver GT, Ryan JJ, DeWolfe AS. Neuropsychological patterns in uremia. J Clin Psychol 1982;38:490-496 (Pubitemid 12047775)
36. Schmahmann JD, Smith EE, Eichler FS et al. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci 2008;1142:266-309
37. Kurella Tamura M. Incidence, management, and outcomes of endstage renal disease in the elderly. Curr Opin Nephrol Hypertens 2009;18:252-257
38. Kurella Tamura M, Wadley V, Yaffe K et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 2008;52:227-234 (Pubitemid 351978145)